Market corrections can be unsettling, particularly when share prices decline sharply and negative headlines dominate investor sentiment. However, periods of market weakness may allow disciplined investors to acquire fundamentally sound ASX-listed companies at more reasonable valuations.
A market correction is generally described as a decline of at least 10% from a recent market high. Corrections may be triggered by interest-rate concerns, geopolitical tensions, weaker economic data, commodity-price movements or disappointing corporate results. While their causes vary, corrections are a normal part of financial-market cycles. At the time of writing, ASX index is trading at the level of ~$9,038.8.
ASX Index (Source: TradingView)
Quality Companies Can Decline with the Broader Market
During a broad market sell-off, investors frequently reduce exposure across several sectors. Consequently, companies with strong balance sheets, established market positions and sustainable cash flows may experience share-price declines even when their long-term fundamentals remain relatively sound.
However, a falling share price does not automatically make a company attractive. Investors must distinguish between a temporary change in market sentiment and a permanent deterioration in a company’s earnings, financial position or industry outlook.
ASX Companies to Assess During a Correction
The following companies illustrate the types of established ASX-listed businesses investors may reassess when market weakness produces more attractive valuations:
- BHP Group Limited (ASX: BHP): BHP provides diversified exposure to iron ore, copper, metallurgical coal and potash. In FY2026, the company generated underlying EBITDA of US$33.0 billion and free cash flow of US$9.8 billion. Strong cash generation and increasing exposure to copper may support its long-term appeal. Nevertheless, commodity-price volatility, operational risks and changes in Chinese demand remain important considerations. At the time of writing, BHP’s shares are trading at the price of $63.67 as on 19 August 2026.
- CSL Limited (ASX: CSL): A meaningful share-price correction may encourage investors to reassess CSL’s global plasma-therapy, vaccine and specialty-medicine businesses. CSL reported FY2026 underlying NPATA of US$3.1 billion, down 2%, while cash flow from operations reached US$3.5 billion. Following restructuring costs and impairments, the company recorded a statutory net loss after tax of US$2.6 billion. CSL’s long-term healthcare position remains notable, although its recovery depends on successful execution of its restructuring and growth strategy. At the time of writing, CSL’s shares are trading at the price of $163.10 as on 19 August 2026.
- Commonwealth Bank of Australia (ASX: CBA): CBA’s leading banking franchise, profitability and dividend profile may make it a defensive watchlist candidate during a correction. The bank delivered FY2026 cash NPAT of approximately A$11.0 billion, up 7%, while pre-provision profit increased 6% to A$16.5 billion. However, investors should remain disciplined about valuation and monitor competition, credit quality, housing activity and interest-rate movements. At the time of writing, CBA’s shares are trading at the price of $160.05 as on 19 August 2026.
These companies are illustrative research candidates—not automatic buying opportunities. Even a high-quality business can deliver weak returns when purchased at an excessive valuation or market headwinds.
Managing Timing Risk
Predicting the exact market bottom is extremely difficult. Investors may instead consider gradually building positions at different price levels. This approach can reduce timing risk and preserve capital if markets weaken further.
Market corrections can create opportunities, but successful investing still requires fundamental research, valuation discipline, diversification and appropriate position sizing. Investors who remain focused on business quality rather than short-term market noise may find compelling long-term opportunities during periods of uncertainty.
Disclaimer: Ace Investors Pty Ltd (ABN 70 637 702 188) authorized representative of MF & CO. ASSET MANAGEMENT PTY LTD (AFSL No.520442). Ace Investors has made all efforts to warrant the reliability and accuracy of the views and recommendations articulated in the reports published on its websites. Ace Investors research is based on the information known to us or which was obtained from various sources which we believed to be reliable and accurate to the best of its knowledge. Ace Investors provides only general financial information through its website, reports and newsletters without considering financial needs or investment objectives of any individual user. We strongly advocate that you seek advice, with your financial planner, advisor or stock broker, the merit of each recommendation before acting on any recommendation for their own specific financial circumstances and realize that not all investments will be suitable for all subscribers. To the scope permitted by law, Ace Investors Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Ace Investors Pty Ltd hereby limits its liability, to the scope permitted by law to resupply of the services. The securities and financial products we study and share information on, in our reports, may have a product disclosure statement or other offer document associated with them. You should obtain a copy of these before making any decision about acquiring any security or product. You can refer to our Financial Services Guide.